Published in Allergy on February 07, 2009
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol (2014) 1.49
Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. Appl Environ Microbiol (2012) 1.06
Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli. J Leukoc Biol (2009) 0.94
CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy (2010) 0.89
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
CD4+CD25high regulatory cells in human peripheral blood. J Immunol (2001) 11.25
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med (2006) 8.41
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med (2001) 5.56
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science (1997) 4.89
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity (2003) 3.55
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med (2002) 3.47
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med (2005) 3.17
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (2004) 3.05
B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol (2001) 2.99
Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol (1998) 2.84
CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood (2004) 2.80
Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med (2004) 2.38
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol (1998) 2.32
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res (2004) 2.28
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood (2005) 1.89
Regulatory T-cell compartmentalization and trafficking. Blood (2006) 1.86
Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol (2002) 1.41
CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J (2004) 1.33
Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur J Immunol (2003) 1.25
Chemokines and their receptors in allergic disease. J Allergy Clin Immunol (2006) 1.21
CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease. J Immunol (2003) 1.21
Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease. J Immunol (2003) 1.19
IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol (2005) 1.13
Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol (2002) 1.03
CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol (2002) 0.99
CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol (2003) 0.97
Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4. J Allergy Clin Immunol (2003) 0.88
CXCR1+CD4+ T cells in human allergic disease. J Immunol (2004) 0.83
Breast cancer: management of the opposite breast. Oncology (Williston Park) (1988) 4.71
Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem Pharmacol (1968) 3.62
How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol (1993) 3.18
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med (1998) 2.94
Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest (1996) 2.92
Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy (2004) 2.00
The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol (1967) 1.99
Clearing-factor lipase in adipose tissue. A medium in which the enzyme activity of tissue from starved rats increases in vitro. Biochem J (1966) 1.94
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics (1975) 1.82
Clearing-factor lipase in adipose tissue. Factors influencing the increase in enzyme activity produced on incubation of tissue from starved rats in vitro. Biochem J (1966) 1.79
Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol (1999) 1.71
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis (1992) 1.68
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol (1993) 1.67
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today (1999) 1.67
Concerns about clinical drug trials. J Clin Psychopharmacol (2000) 1.67
Clearing-factor lipase in adipose tissue. Studies with puromycin and actinomycin. Biochem J (1968) 1.66
Early discharge after mastectomy. A safe way of diminishing hospital costs. Am Surg (1987) 1.61
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Clearing-factor lipase in adipose tissue. Distinction of different states of the enzyme and the possible role of the fat cell in the maintenance of tissue activity. Biochem J (1969) 1.57
Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba. Clin Exp Allergy (2008) 1.56
First x-ray scattering studies on electrostatically levitated metallic liquids: demonstrated influence of local icosahedral order on the nucleation barrier. Phys Rev Lett (2003) 1.51
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.50
Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol (2000) 1.49
How is difficult asthma managed? Eur Respir J (2006) 1.47
Interaction of warfarin and nonsystemic gastrointestinal drugs. Clin Pharmacol Ther (1971) 1.44
Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol (1992) 1.42
Effect of nutritional status on rat adipose tissue, muscle and post-heparin plasma clearing factor lipase activities: their relationship to triglyceride fatty acid uptake by fat-cells and to plasma insulin concentrations. Clin Sci Mol Med (1976) 1.34
The significance of changes in tissue clearing-factor lipase activity in relation to the lipaemia of pregnancy. Biochem J (1968) 1.34
Placebo-controlled dose-ranging trial designs in phase II development of nefazodone. Psychopharmacol Bull (1990) 1.30
Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci (2007) 1.26
Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J Leukoc Biol (1999) 1.24
Total axillary lymphadenectomy in the management of breast cancer. Arch Surg (1991) 1.24
Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol (2012) 1.22
A multiple-dose, controlled study of phenelzine in depression-anxiety states. Arch Gen Psychiatry (1976) 1.22
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain (1996) 1.21
The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart. J Lipid Res (1970) 1.20
Clinical pharmacology of phenelzine. Arch Gen Psychiatry (1978) 1.19
The effect of a non-ionic detergent (Triton WR 1339) on the removal of triglyceride fatty acids from the blood of the rat. J Physiol (1967) 1.19
TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy (1991) 1.17
Interaction of commonly prescribed drugs and warfarin. Ann Intern Med (1970) 1.17
Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis (1992) 1.17
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol (2000) 1.15
The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responese in man. Clin Pharmacol Ther (1969) 1.15
Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol (1993) 1.14
Inhaled house dust mite induces pulmonary T helper 2 cytokine production. Clin Exp Allergy (2009) 1.14
Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet (1996) 1.13
Effect of fasting on the clearing factor lipase (lipoprotein lipase) activity of fresh and defatted preparations of rat heart muscle. J Lipid Res (1970) 1.13
Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry (1977) 1.12
Metabolism of triglyceride fatty acid by the perfused rat heart. Biochem J (1967) 1.12
Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum (1977) 1.11
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol (1992) 1.08
The heterogeneity of the lipoprotein lipase of rat epididymal adipose tissue. Biochem J (1978) 1.08
Studies on tissue clearing factor lipase related to its role in the removal of lipoprotein triglyceride from the plasma. Biochem Soc Symp (1971) 1.08
Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. J Clin Psychiatry (1996) 1.08
Concern about aspects of body image and adjustment to early stage breast cancer. Psychosom Med (1998) 1.08
Optimism versus pessimism predicts the quality of women's adjustment to early stage breast cancer. Cancer (1994) 1.07
Biophysically based mathematical modeling of interstitial cells of Cajal slow wave activity generated from a discrete unitary potential basis. Biophys J (2009) 1.06
Genetic control of platelet and plasma monoamine oxidase activity. Arch Gen Psychiatry (1973) 1.06
Effects of cold exposure on heart clearing factor lipase and triglyceride utilization in the rat. J Lipid Res (1974) 1.05
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery (1978) 1.05
Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. J Clin Oncol (1992) 1.05
Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol (2012) 1.04
Effect of clofibrate on glucose tolerance in maturity onset diabetes. Br J Clin Pharmacol (1977) 1.04
Further studies on tryptophan hydroxylase in rat brainstem and beef pineal. Biochem Pharmacol (1969) 1.04
Clearing-factor lipase in adipose tissue. A possible role of adenosine 3',5'-(cyclic)-monophosphate in the regulation of its activity. Biochem J (1968) 1.04
Post-translational regulation of lipoprotein lipase activity in adipose tissue. Biochem J (1978) 1.03
Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy (2002) 1.03
Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer (1986) 1.02
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science (1979) 1.01
The effect of cycloheximide on adipose-tissue clearing-factor lipase. Biochem J (1973) 1.01
Hormonal control of adipose tissue clearing factor lipase activity. FEBS Lett (1974) 1.01
The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. J Neurochem (1979) 1.00
Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy (2005) 0.99
A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy (2011) 0.99
Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol (1998) 0.98
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology (1993) 0.98
Allergen-induced airway remodelling. Eur Respir J (2007) 0.98
Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood (2000) 0.98
The clearing-factor lipase activity of isolated fat-cells. Biochem J (1975) 0.97
Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax (1996) 0.97
Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease. Allergy (2014) 0.97
Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. J Clin Pathol (1988) 0.97
Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy (2010) 0.96
The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial. Arch Gen Psychiatry (1973) 0.96
Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy? J Clin Psychopharmacol (1984) 0.96
Ageing, monoamines, and monoamine-oxidase levels. Lancet (1972) 0.95
Chemokines, innate and adaptive immunity, and respiratory disease. Eur Respir J (2002) 0.95
Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy (2010) 0.94
Cost-effective management of breast cancer. Cancer (1992) 0.93
Changes associated with the production of fatty livers by white phosphorus and by ethanol in the rat. Biochem J (1964) 0.93
Primary plasma cell leukaemia: immunological and ultrastructural studies in 6 cases. Scand J Haematol (1985) 0.92
Clearing factor lipase (lipoprotein lipase) activator. A method for the measurement of the net activating ability of human sera. Atherosclerosis (1976) 0.92